EP Patent

EP0124363A2 — Photochemical decontamination treatment of whole blood or blood components

Assigned to Bayer Corp · Expires 1984-11-07 · 42y expired

What this patent protects

Biological compositions are freed of functional polynucleotides by treatment of the biological composition with psoralen derivatives under irradiation conditions in which the proteins retain their original physiological activities and any polynucleotide present is rendered inacti…

USPTO Abstract

Biological compositions are freed of functional polynucleotides by treatment of the biological composition with psoralen derivatives under irradiation conditions in which the proteins retain their original physiological activities and any polynucleotide present is rendered inactive.

Drugs covered by this patent

Patent Metadata

Patent number
EP0124363A2
Jurisdiction
EP
Classification
—
Expires
1984-11-07
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.